These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6107740)
1. Adjuvant levamisole in breast cancer. Lancet; 1980 Nov; 2(8204):1133-4. PubMed ID: 6107740 [No Abstract] [Full Text] [Related]
2. Levamisole granulocytopenia in patients receiving an adjuvant chemoimmunotherapy program after surgery for breast carcinoma with axillary lymph node involvement. Vogel CL; Lipscomb DL; Silverman MA; Kerns AL; Mansell PW; Sugarbaker EV Cancer Treat Rep; 1978 Oct; 62(10):1587-9. PubMed ID: 709561 [No Abstract] [Full Text] [Related]
3. High frequency of agranulocytosis in breast-cancer patients treated with levamisole. Teerenhovi L; Heinonen E; Gröhn P; Klefström P; Mehtonen M; Tiilikainen A Lancet; 1978 Jul; 2(8081):151-2. PubMed ID: 78345 [No Abstract] [Full Text] [Related]
4. Agranulocytosis in breast-cancer patients treated with levamisole. Retsas S; Phillips RH; Hanham IW; Newton KA Lancet; 1978 Aug; 2(8084):324-5. PubMed ID: 79122 [No Abstract] [Full Text] [Related]
5. Increased breast-cancer recurrence rate after adjuvant therapy with levamisole. A preliminary report. Executive Committee of the Danish Breast Cancer Cooperative Group. Lancet; 1980 Oct; 2(8199):824-7. PubMed ID: 6107500 [TBL] [Abstract][Full Text] [Related]
6. The dosage regimen of levamisole in cancer: is it related to efficacy and safety? Amery WK; Butterworth BS Int J Immunopharmacol; 1983; 5(1):1-9. PubMed ID: 6341264 [No Abstract] [Full Text] [Related]
7. [Letter: Agranulocytosis during rheumatoid arthritis treated by levamisole]. Leca AP; Le Porrier M; Prier A; Camus JP Nouv Presse Med; 1976 May; 5(18):1212. PubMed ID: 1272791 [No Abstract] [Full Text] [Related]
8. [Case of agranulocytosis during treatment of rheumatoid arthritis with levamisole]. Kierat J Reumatologia; 1979; 17(1):43-6. PubMed ID: 451382 [No Abstract] [Full Text] [Related]
10. Agranulocytosis due to levamisole. Graber H; Takacs L; Vedrödy K Lancet; 1976 Dec; 2(7997):1248. PubMed ID: 63070 [No Abstract] [Full Text] [Related]
11. Levamisole in the treatment of stage II breast cancer. Five-year follow-up of a randomized double-blind study. Klefström P; Holsti P; Gröhn P; Heinonen E; Holsti L Cancer; 1985 Jun; 55(12):2753-7. PubMed ID: 2986823 [TBL] [Abstract][Full Text] [Related]
12. Levamisole as adjuvant immunotherapy in breast cancer. Treurniet-Donker AD; Meischke-de Jongh ML; van Putten WL Cancer; 1987 May; 59(9):1590-3. PubMed ID: 3828958 [TBL] [Abstract][Full Text] [Related]
13. B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole. Mielants H; Veys EM Acta Rhumatol; 1979; 3(2):104-7; discussion 107-9. PubMed ID: 11496648 [No Abstract] [Full Text] [Related]
14. Levamisole and agranulocytosis. Ruuskanen O; Remes M; Mäkela AL; Isomäki H; Toivanen A Lancet; 1976 Oct; 2(7992):958-9. PubMed ID: 62180 [No Abstract] [Full Text] [Related]
15. Recurrent agranulocytosis after levamisole. Vanholder R; Van Hove W Lancet; 1977 Jan; 1(8002):100. PubMed ID: 63701 [No Abstract] [Full Text] [Related]